Table 3.
Multivariable binary logistic regression analysis for the Alberta stroke program early CT score subregions related to 3-month poor functional outcome
| Unadjusted OR | 95% CI | P-value | Adjusted OR | 95% CI | P-value | |
|---|---|---|---|---|---|---|
| Reperfusion therapy cohort | ||||||
| Left - M4 | 3.75 | 1.10–12.74 | 0.034 | 5.39 | 1.53–19.02 | 0.009 |
| Right - M3 | 3.64 | 1.04–12.82 | 0.044 | 4.21 | 1.05–16.78 | 0.013 |
| Medical therapy cohort | ||||||
| Left - Caudate nucleus | 5.27 | 1.76–15.80 | 0.003 | 3.14 | 1.00–9.85 | 0.049 |
| Left - M5 | 2.88 | 1.14–7.27 | 0.025 | 2.87 | 1.08–7.59 | 0.034 |
| Right - Internal capsule | 4.83 | 1.59–14.67 | 0.006 | 3.94 | 1.22–12.78 | 0.022 |
| Right - M3 | 3.16 | 1.33–7.53 | 0.009 | 4.15 | 1.29–8.18 | 0.013 |
For the reperfusion therapy cohort, the adjusted model additionally adjusted for age, sex, baseline NIHSS, total ASPECTS score, arterial occlusion sites, and treatment options. For the medical therapy cohort, the adjusted model additionally adjusted for baseline NIHSS, total ASPECTS score, and arterial occlusion sites. OR: odds ratio; CI: confidence interval; NIHSS: National Institutes of Health Stroke Scale; ASPECTS: Alberta Stroke Program CT Score. The bold fonts indicate statistical significance (P < 0.05).